Is CBL-514 a Peptide or a Small Molecule?
Caliway describes CBL-514 as a small-molecule investigational drug candidate, not a peptide. A vial presentation or placement in a peptide supplierβs catalog does not change its chemical classification.
Why the classification question comes up
People often encounter CBL-514 beside peptide products and assume that the same category applies. Catalog navigation is a shopping aid, however, not a chemical identification method. The developerβs research description identifies CBL-514 as a small molecule.[1]
A clear research note should preserve the compoundβs name and distinguish the name from its class, formulation and intended experimental use. Those fields answer different questions. Mixing them can lead readers to attach unrelated peptide assumptions to a compound for which they have not been demonstrated.
Four labels that should stay separate
| Label | What it tells you |
|---|---|
| CBL-514 | The development name being discussed |
| Small molecule | The developerβs classification |
| Powder in a vial | The format described by a particular supplier |
| 20 mg | A labeled amount, requiring separate analytical verification |
The DA listing currently describes a 20 mg powder vial. That description identifies the offered format; it does not supply a molecular structure, sequence or proof of equivalence to clinical material.[2]
How to write an accurate compound record
Use separate fields for the source of the classification, the supplierβs specification and the laboratoryβs findings. Record unresolved identity details explicitly. Do not copy a molecular formula, sequence or registry identifier from an unverified marketplace listing simply to complete the form.
For example, a sensible entry might say βdeveloper classification: small molecule; supplied format: powder; lot-specific identity evidence: awaiting review.β This preserves what is known without turning an assumption into a measured result. It also makes the next documentation request clear.
Classification alone does not settle solubility, compatibility, stability or biological activity. Each requires evidence relevant to the material and conditions being evaluated.
Frequently asked questions
Does CBL-514 have a peptide sequence?
The developer describes it as a small molecule. A peptide sequence should not be assigned on the basis of a supplier category.
Does a small-molecule label confirm sample identity?
No. Classification is background information; identifying a supplied sample requires appropriate analytical evidence.
CBL-514 product and documentation
Review the current format and pack choices, then match the supplied lot to its documentation. No batch-specific identity, purity or content result is asserted in this article.
